The Transcription Factor c-Jun Protects against Liver Damage following Activated β-Catenin Signaling

Background: The Wnt/beta-Catenin signaling pathway is central for liver functions and frequently deregulated in hepatocellular carcinoma (HCC). Analysis of the early phenotypes and molecular events following beta-Catenin activation is therefore essential for better understanding HCC pathogenesis. The AP-1 transcription factor c-Jun is a putative beta-Catenin target gene and promotes hepatocyte survival, proliferation, and liver tumorigenesis, suggesting that c-Jun may be a key target of beta-Catenin signaling in the liver. Methodology/Principal Findings: To address this issue, the immediate hepatic phenotypes following deletion of the tumor suppressor Apc and subsequent beta-Catenin activation were analyzed in mice. The contribution of c-Jun to these phenotypes was dissected in double mutant animals lacking both, Apc and c-Jun. beta-Catenin was rapidly activated in virtually all Apc mutant hepatocytes while c-Jun was induced only after several days, suggesting that its expression was rather a secondary event following Apc deletion in the liver. Loss of Apc resulted in increased hepatocyte proliferation, hepatomegaly, deregulated protein metabolism, and premature death. Interestingly, additional deletion of c-Jun did not affect hepatocyte proliferation but resulted in increased liver damage and mortality. This phenotype correlated with impaired expression of hepatoprotective genes such as Birc5, Egfr Igf1 and subsequently deregulated Akt signaling. Conclusions/Significance: These data indicate that c-Jun is not a primary target of beta-Catenin signaling in the liver, but rather protects against liver damage, which in turn may promote liver tumorigenesis.